As of 2:51pm ET
| -0.01 / -1.56%|
The 1 analysts offering 12-month price forecasts for Titan Pharmaceuticals Inc have a median target of 1.25, with a high estimate of 1.25 and a low estimate of 1.25. The median estimate represents a +98.41% increase from the last price of 0.63.
The current consensus among 1 polled investment analysts is to Buy stock in Titan Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.